BusinessArch Biopartners Announces Issuance of U.S. Patent for Its Novel Antibacterial Drug AB569, Designed to Target Chronic Infection and Antibiotic ResistanceBy Nasdaq OMXMar 27, 2018, 1:08 PM UTC
BusinessMelinta Therapeutics’ Topical Radezolid Well Tolerated in Phase 1 Study for Treatment of AcneBy Nasdaq OMXOct 10, 2017, 12:00 PM UTC
